Insights Ahead: Royalty Pharma's Quarterly Earnings

Royalty Pharma (NASDAQ:RPRX) is preparing to release its quarterly earnings on Wednesday, 2024-11-06. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Royalty Pharma to report an earnings per share (EPS) of $0.93.

Investors in Royalty Pharma are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings Track Record

During the last quarter, the company reported an EPS missed by $0.03, leading to a 0.42% increase in the share price on the subsequent day.

Here's a look at Royalty Pharma's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.99

0.99

0.99

0.77

EPS Actual

0.96

0.98

1.15

0.79

Price Change %

0.0%

0.0%

-0.0%

-1.0%

Insights Shared by Analysts on Royalty Pharma

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Royalty Pharma.

With 2 analyst ratings, Royalty Pharma has a consensus rating of Buy. The average one-year price target is $45.5, indicating a potential 67.28% upside.

Analyzing Analyst Ratings Among Peers

This comparison focuses on the analyst ratings and ...